» Authors » Frank Stoblen

Frank Stoblen

Explore the profile of Frank Stoblen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 49
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruland A, Hagemann F, Reinisch M, Holtschmidt J, Kummel A, Dittmer-Grabowski C, et al.
Breast Care (Basel) . 2018 Jun; 13(2):116-120. PMID: 29887788
Background: This study presents first feasibility experiences with a new 3-dimensional (3D) marker clip system in clinical practice. The rate of clinical complete responses in the treatment of breast cancer...
2.
Stoblen F, Rezai M, Kummel S
Insights Imaging . 2012 Feb; 1(2):93-97. PMID: 22347910
BACKGROUND: The First International Breast (Implant) Conference was held by the EAoS® (European Academy of Senology) in cooperation with the German Society of Senology during its 29th annual meeting in...
3.
Landt S, Mordelt K, Schwidde I, Barinoff J, Korlach S, Stoblen F, et al.
Anticancer Res . 2011 Jul; 31(8):2651-5. PMID: 21778318
Background/aim: Angiogenesis plays a key role in tumour growth and metastasis. Expression of angiogenic factors has been suggested as a marker for tumour malignity, and it may help to identify...
4.
Landt S, Heidecke H, Reuter C, Korlach S, Blohmer J, Lichtenegger W, et al.
Anticancer Res . 2011 Jul; 31(8):2645-9. PMID: 21778317
Background/aim: Angiogenesis plays a key role in tumour growth and metastasis. Expression of angiogenic factors has been suggested as a marker for tumour malignity, and may help to assess a...
5.
Eggeman H, Stoblen F, Thill M, Korlach S, Schmid P, Luftner D, et al.
Anticancer Res . 2011 Jul; 31(8):2617-22. PMID: 21778313
Background/aim: The aim of the present study was to investigate the effects of conventional and dose-dense chemotherapy on serum levels of soluble adhesion molecules sICAM-1 and sVCAM-1 in node-positive patients...
6.
Landt S, Wehling M, Heidecke H, Jeschke S, Korlach S, Stoblen F, et al.
Anticancer Res . 2011 Jul; 31(8):2589-95. PMID: 21778309
Background/aim: Angiogenesis is pivotal in tumour development and progress, and targeted tumour therapies, such as bevacizumab, have shown promising results. However, in unselected patient populations, the treatment with angiogenesis-targeted combination...
7.
Stoblen F, Landt S, Ishaq R, Stelkens-Gebhardt R, Rezai M, Skaane P, et al.
Anticancer Res . 2011 Jul; 31(8):2575-81. PMID: 21778307
Aim: To retrospectively evaluate the diagnostic value of high-frequency ultrasound for the detection of microcalcifications screening in BI-RADS 4a patients. Patients And Methods: A total of 52 women (mean age...
8.
Stoblen F, Landt S, Stelkens-Gebhardt R, Sehouli J, Rezai M, Kummel S
Anticancer Res . 2011 Jul; 31(8):2569-74. PMID: 21778306
Background/aim: Automated ultrasound examination of suspicious findings can reduce the physician's workload in screening mammography. The present study examines the diagnostic accuracy of this method in comparison to mammography as...